Atopic dermatitis (AD) is a chronic inflammatory and relapsing cutaneous disease characterized by pruritus, cutaneous inflammation, and transepidermal water loss (Krakowski 2008). The incidence of AD in industrialized nations has increased by 2- to 3-fold over 30 years– it is estimated to affect between 15% and 30% of children in industrialized nations and up to 10% of adults (Bieber 2010; Silverberg 2013). The economic burden associated with AD is significant, with direct health care costs and indirect costs, such as those associated with missed work, estimated at $1000 per patient annually in the United States, and total estimated annual costs of $5.297 billion in 2015 (Drucker 2017; Mallett 2007).
The increasing incidence of AD and poor recognition of the disease in some patient groups is a public health concern. Also, there are disparities in the diagnosis and management of African Americans ( Cohen 2020). AD symptoms and its daily management cause significant effects on quality of life for both patients and caregivers. AD is associated with an increase in other atopic manifestations as well as with serious comorbidities that can significantly affect overall patient health and wellbeing (Silverberg 2015; Simpson 2012; Yu 2016; Zheng 2011).
Recognizing our role in reducing these disparities, LiVDerm aims to educate clinicians and care teams – evidence-based prevention and treatment plans, especially in the community where most health is affected to enhance the care of patients from different racial and ethnic groups.
|I.||Introduction: Evaluating the Burden of AD in African Americans|
|II.||Factors Contributing to Care Disparities in African American Population|
|III.||Evaluating and Screening for AD in AA Patients|
|IV.||Patient Case Evaluation: Strategies for Diagnosing and Treating AD in AA Patients|
|V.||Optimizing AD treatment in African American population|
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and LivDerm in collaboration with Postgraduate Institute for Medicine.
This activity is supported by an independent educational grant from Incyte.
Target Audience: These activities are designed for an audience of physicians, nurses, pharmacists, and professional staff members of medical practices specializing in dermatology and allergy/immunology.
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and LivDerm. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™️. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
1 contact hour may be earned for successful completion of this activity.
Pharmacist Continuing Education
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program has been developed according to the ACPE Criteria for Quality and is assigned ACPE Universal Activity #0797-9999-21-104-L01-P. This program is designated for up to 1 contact hours (0.1 CEUs) of continuing pharmacy education credit.
Type of Activity: Application
Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser.
A computer or device with an internet connection.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Disclosure of Conflicts of Interest
The Annenberg Center for Health Sciences at Eisenhower requires all individuals who are in a position to control the content of this activity to disclose all their financial relationships with ineligible companies. All identified COI are thoroughly mitigated according to the Annenberg Center for Health Sciences at Eisenhower’s policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.